Bibliography For Retatrutide

Every Curated Peer-Reviewed Reference Indexed For This Compound. Each Citation Can Be Exported In BibTeX, RIS, EndNote, Or Plain Text.

Indexed Types:labelmonographrctstudy
2023 - rct - Pivotal Reference

Triple-Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial

Jastreboff AM et al.. N Engl J Med.

n.d. - monograph

RxNorm 2722410 (Retatrutide)

Unknown Authors.

n.d. - study

Rationale, design and baseline characteristics of the TRANSCEND-CKD trial of retatrutide in patients with chronic kidney disease.

Unknown Authors.

n.d. - study

Multi-omic profiling reveals Retatrutide alleviates adipose tissue fibrosis via metabolic reprogramming and tissue repair.

Unknown Authors.

n.d. - study

Retatrutide Shows Multiple Metabolic Benefits in Diet-Induced Obese MASH Mouse and Hamster Models.

Unknown Authors.

n.d. - study

Do no harm: managing nausea and vomiting in GLP-1 based obesity therapies.

Unknown Authors.

n.d. - study

Association between patient-reported eating behaviours and weight change: Secondary analyses of a randomized, double-blind trial comparing retatrutide and placebo in people with obesity or overweight.

Unknown Authors.

n.d. - label

RETATRUTIDE PEN INJECTION, SOLUTION [GUANGZHOU YIXIN CROSS-BORDER E-COMMERCE CO., LTD.]

Unknown Authors.

n.d. - study

GLP-1 Agonists in Adolescent Obesity: A Narrative Review of Single, Dual, and Triple Agonists.

Unknown Authors.

n.d. - study

Comparative Efficacy and Safety of Glucagon Receptor Agonists on Metabolic Outcomes: A Network Meta-Analysis of Randomised Controlled Trials.

Unknown Authors.

n.d. - study

GIPR:GCGR co-agonism restores normal weight in obese rodents.

Unknown Authors.

n.d. - study

Evolution of incretin-based therapies: From GLP-1 monotherapy to dual and triple agonists: A new era in metabolic therapy.

Unknown Authors.

n.d. - study

Efficacy of GLP-1 analog peptides, semaglutide, tirzepatide, and retatrutide on MC4R deficient obesity and their comparison.

Unknown Authors.

n.d. - study

Perceived benefits of treatment for obesity with retatrutide: A qualitative study of patients in a phase 2 clinical trial.

Unknown Authors.

n.d. - study

Innovative Diabetes Therapies and Impact on Peripheral and Autonomic Diabetic Neuropathies: A State-of-the-Art Review.

Unknown Authors.

n.d. - study

Dysesthesia associated with GLP-1 agonist therapies: data-mining analysis and literature review.

Unknown Authors.

n.d. - study

Appetite, eating attitudes, and eating behaviours during treatment with retatrutide in adults with type 2 diabetes: Results of a phase 2 study.

Unknown Authors.

n.d. - study

Metabolic Dysfunction-Associated Steatotic Liver Disease and Incretin Receptor Agonists: A Metabolic Approach to Halting Liver Disease Progression.

Unknown Authors.

n.d. - study

Acute Contractile Effects of Glucagon-like-Peptide-1 Receptor Agonists in the Human Heart.

Unknown Authors.

n.d. - study

The use of GLP-1 receptor agonists and co-agonists in adults without diabetes: a systematic review and network meta-analysis protocol.

Unknown Authors.

n.d. - study

Retatrutide for the treatment of obesity, obstructive sleep apnea and knee osteoarthritis: Rationale and design of the TRIUMPH registrational clinical trials.

Unknown Authors.

n.d. - study

Comment on Huttasch et al. Increased Early Postprandial Glucagon Concentrations in Humans With Newly Diagnosed Type 2 Diabetes and Steatotic Liver Disease.

Unknown Authors.

n.d. - study

The Effects of SGLT2 Inhibitors on Muscle Health in Older Adults: A Systematic Review and Meta-Analysis.

Unknown Authors.

n.d. - study

The Effects of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists on Polycystic Ovarian Syndrome: A Scoping Review.

Unknown Authors.

n.d. - study

Triple Agonism Based Therapies for Obesity.

Unknown Authors.

n.d. - study

Future Directions in the Medical Treatment of Obesity: A Narrative Review.

Unknown Authors.

n.d. - study

Decreases in circulating ANGPTL3/8 concentrations following retatrutide treatment parallel reductions in serum lipids.

Unknown Authors.

n.d. - study

Inotropic effects of retatrutide in isolated human atrial preparations.

Unknown Authors.

n.d. - study

Evaluating the Rates of Pancreatitis and Pancreatic Cancer Among GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.

Unknown Authors.

n.d. - study

GLP-1 receptor agonists and cancer: current clinical evidence and translational opportunities for preclinical research.

Unknown Authors.